GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Luyan Pharma Co Ltd (SZSE:002788) » Definitions » Additional Paid-In Capital

Luyan Pharma Co (SZSE:002788) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Luyan Pharma Co Additional Paid-In Capital?


Luyan Pharma Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥628 Mil) but then stayed the same from Dec. 2023 (¥628 Mil) to Mar. 2024 (¥0 Mil).

Luyan Pharma Co's annual additional paid-in capital declined from Dec. 2021 (¥653 Mil) to Dec. 2022 (¥651 Mil) and declined from Dec. 2022 (¥651 Mil) to Dec. 2023 (¥628 Mil).


Luyan Pharma Co Additional Paid-In Capital Historical Data

The historical data trend for Luyan Pharma Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Luyan Pharma Co Additional Paid-In Capital Chart

Luyan Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 456.79 727.38 653.37 650.60 628.05

Luyan Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 650.77 - 628.05 -

Luyan Pharma Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Luyan Pharma Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Luyan Pharma Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Luyan Pharma Co (SZSE:002788) Business Description

Traded in Other Exchanges
N/A
Address
1004 Ridge Road, Huli District, Fujian Province, Xiamen City, CHN, 361 010
Luyan Pharma Co Ltd, formerly Luyan (Fujian) Pharma Co Ltd engages in the production, operation, distribution, and retail of human health products in China. It provides medical and health products.
Executives
Zhu Ming Guo Executives
Yang Cong Jin Directors, executives
Lei Ming Directors, executives
Li Wei Yang Executives
Cai Mei Zhen Supervisors
Li Cui Ping Supervisors
Wu Jin Xiang Directors, executives
Zhang Jun Ying Executives
Wu Huo Lu Director

Luyan Pharma Co (SZSE:002788) Headlines

No Headlines